Literature DB >> 22214474

Recognizing the link between chronic kidney disease and cardiovascular disease.

Matthew R Weir1.   

Abstract

The prevalence of chronic kidney disease (CKD) is rising in the United States, and cardiovascular disease (CVD) is increasingly recognized to occur at elevated rates in patients with CKD compared with the general population. The impact of CVD in patients with CKD is significant, inversely related to the level of kidney function, and exaggerated when compared with matched patients without CKD. CKD is associated with an increased risk of CVD, CVD events, and death, but the prevalence of traditional CVD risk factors is also increased compared with the general population. Proteinuria, hypertension, dyslipidemia, and diabetes are common in patients with CKD and contribute directly to CVD events. CKD-related factors (eg, disorders of electrolyte and mineral metabolism, anemia, and vascular calcification) also contribute to mortality associated with CKD.

Entities:  

Mesh:

Year:  2011        PMID: 22214474

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  7 in total

1.  Potential Role of H-Ferritin in Mitigating Valvular Mineralization.

Authors:  Katalin Éva Sikura; László Potor; Tamás Szerafin; Abolfazl Zarjou; Anupam Agarwal; Paolo Arosio; Maura Poli; Zoltán Hendrik; Gábor Méhes; Melinda Oros; Niké Posta; Lívia Beke; Ibolya Fürtös; György Balla; József Balla
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-03       Impact factor: 8.311

Review 2.  Vascular calcification in diabetes: mechanisms and implications.

Authors:  Janet K Snell-Bergeon; Matthew J Budoff; John E Hokanson
Journal:  Curr Diab Rep       Date:  2013-06       Impact factor: 4.810

Review 3.  Regression of vascular calcification in chronic kidney disease - feasible or fantasy? a review of the clinical evidence.

Authors:  Oscar Leonard; Jonas Spaak; David Goldsmith
Journal:  Br J Clin Pharmacol       Date:  2013-10       Impact factor: 4.335

4.  Prescribed Renoprotective Chinese Herbal Medicines Were Associated with a Lower Risk of All-Cause and Disease-Specific Mortality among Patients with Chronic Kidney Disease: A Population-Based Follow-Up Study in Taiwan.

Authors:  Chuan-Fa Hsieh; Huan-Cheng Chang; Song-Lih Huang; Chien-Lung Chen; Wei-Ta Chen; Chen-Chang Yang
Journal:  Evid Based Complement Alternat Med       Date:  2017-07-17       Impact factor: 2.629

Review 5.  Preventive and therapeutic effects of MG132 by activating Nrf2-ARE signaling pathway on oxidative stress-induced cardiovascular and renal injury.

Authors:  Wenpeng Cui; Yang Bai; Ping Luo; Lining Miao; Lu Cai
Journal:  Oxid Med Cell Longev       Date:  2013-03-07       Impact factor: 6.543

6.  Assessment of physical activity in patients with chronic kidney disease and renal replacement therapy.

Authors:  William S G Hayhurst; Aimun Ahmed
Journal:  Springerplus       Date:  2015-09-21

7.  Deregulated Renal Calcium and Phosphate Transport during Experimental Kidney Failure.

Authors:  Wilco P Pulskens; Melissa Verkaik; Fareeba Sheedfar; Ellen P van Loon; Bart van de Sluis; Mark G Vervloet; Joost G Hoenderop; René J Bindels
Journal:  PLoS One       Date:  2015-11-13       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.